# Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine

> **NCT00454987** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 288 (actual)

## Conditions studied

- Haemophilus Influenzae Type b
- Neisseria Meningitidis
- Neisseria Meningitidis-Haemophilus Influenzae Type b Vaccine

## Interventions

- **BIOLOGICAL:** Menitorix
- **BIOLOGICAL:** Infanrix IPV

## Key facts

- **NCT ID:** NCT00454987
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05-16
- **Primary completion:** 2007-10-12
- **Final completion:** 2007-10-12
- **Target enrollment:** 288 (ACTUAL)
- **Last updated:** 2020-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00454987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00454987, "Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00454987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*